Additional File 8: of Epithelial-mesenchymal Transition Markers Screened in a Cell-Based Model and Validated in Lung Adenocarcinoma

Jing Song,Wenqing Wang,Yingyan Wang,Yongxin Qin,Yingzi Wang,Jian Zhou,Xuelian Wang,Yi Zhang,Zhihui Wang

DOI: https://doi.org/10.6084/m9.figshare.8863109

2019-01-01

Abstract:Table S3. GO biological process terms and pathways of genes from Blue and Yellow module genes. (XLSX 10 kb)

What problem does this paper attempt to address?

Additional File 1 of Integration of Single-Cell Regulon Atlas and Multi-Omics Data for Prognostic Stratification and Personalized Treatment Prediction in Human Lung Adenocarcinoma

Yi Xiong,Yihao Zhang,Yu Yao,Yueshuo Li,Hongwei Liu,Qian Yang,Yu Chen,Xia Zhang,Xin Chen,Siyi Wanggou,Xuejun Li

DOI: https://doi.org/10.6084/m9.figshare.23751836

2023-01-01

Abstract:Additional file 1: Table S1. Basic information of included datasets. Table S2. Identification of prognostic regulons. Table S3. LPRI of all included datasets.
Supplementary Methods and References from MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer

Su Li,Yongli Luo,Yang Liu,Jing Yang,Chao Yao,Cheng Fang,Juanjuan Shan,Jun Chen,Fangfang Li,Limei Liu,Chungang Liu,Yong Xu,Lupin Jiang,Deyu Guo,Jesús Prieto,Matías A. Ávila,Junjie Shen,Cheng Qian

DOI: https://doi.org/10.1158/0008-5472.22412124.v1

2023-01-01

Abstract:Description of additional methods and procedures used in the study. Also includes Supplementary References.
Supplementary Table 2 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Lauren Averett Byers,Jing Wang,Monique B. Nilsson,Junya Fujimoto,Pierre Saintigny,John Yordy,Uma Giri,Michael Peyton,You Hong Fan,Lixia Diao,Fatemeh Masrorpour,Li Shen,Wenbin Liu,Boris Duchemann,Praveen Tumula,Vikas Bhardwaj,James Welsh,Stephanie Weber,Bonnie S. Glisson,Neda Kalhor,Ignacio I. Wistuba,Luc Girard,Scott M. Lippman,Gordon B. Mills,Kevin R. Coombes,John N. Weinstein,John D. Minna,John V. Heymach

DOI: https://doi.org/10.1158/2159-8290.22528425

2023-01-01

Abstract:PDF file, 64K, Non-small cell lung cancer cell lines.
Supplementary Table 2 from MEK Inhibition Modulates Cytokine Response to Mediate Therapeutic Efficacy in Lung Cancer

Mengyu Xie,Hong Zheng,Ranjna Madan-Lala,Wenjie Dai,Nicholas T. Gimbrone,Zhihua Chen,Fumi Kinose,Sarah A. Blackstone,Keiran S.M. Smalley,W. Douglas Cress,Eric B. Haura,Uwe Rix,Amer A. Beg

DOI: https://doi.org/10.1158/0008-5472.22422747

2023-01-01

Abstract:Drug screening data used in Figure 2 are shown, including drug names, cell viability and expression levels of chemokines.
Supplementary Table 7 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Lauren A. Byers,Jing Wang,Monique B. Nilsson,Junya Fujimoto,Pierre Saintigny,John S. Yordy,Uma Giri,Michael Peyton,You Hong Fan,Lixia Diao,Fatemeh Masrorpour,Li Shen,Wenbin Liu,Boris Duchemann,Praveen K. Tumula,Vikas Bhardwaj,James Welsh,Stephanie Weber,Bonnie S. Glisson,Neda Kalhor,Ignacio I. Wistuba,Luc Girard,Scott M. Lippman,Gordon B. Mills,Kevin R. Coombes,John N. Weinstein,John D. Minna,John V. Heymach

DOI: https://doi.org/10.1158/2159-8290.22528410.v1

2023-01-01

Abstract:PDF file, 95K, Antibodies used in reverse-phase protein microarrays
Additional File 8 of the Immune Subtypes and Landscape of Sarcomas

Wei‐Hung Weng,Yuling Lin,Zhang Li,Cong Tan,Jiaoyan Lv,I Weng Lao,Wenhuo Hu,Zhenzhong Deng,Zebing Liu,Jian Wang,Ming Xu

DOI: https://doi.org/10.6084/m9.figshare.21202086

2022-01-01

Abstract:Additional file8. Table S5: List of six prognostic genes in the blue module.
Epithelial-mesenchymal Transition Markers Screened in a Cell-Based Model and Validated in Lung Adenocarcinoma

Jing Song,Wenqing Wang,Yingyan Wang,Yongxin Qin,Yingzi Wang,Jian Zhou,Xuelian Wang,Yi Zhang,Qi Wang

DOI: https://doi.org/10.1186/s12885-019-5885-9

IF: 4.638

2019-01-01

BMC Cancer

Abstract:Background Re-capture of the differences between tumor and normal tissues observed at the patient level in cell cultures and animal models is critical for applications of these cancer-related differences. The epithelial-mesenchymal transition (EMT) process is essential for tumor migratory and invasive capabilities. Although plenty of EMT markers are revealed, molecular features during the early stages of EMT are poorly understood. Methods A cell-based model to induce lung cell (A549) EMT using conditioned medium of in vitro cancer activated fibroblast (WI38) was established. High-throughput sequencing methods, including RNA-seq and miRNA-seq, and advanced bioinformatics methods were used to explore the transcriptome profile transitions accompanying the progression of EMT. We validated our findings with experimental techniques including transwell and immunofluorescence assay, as well as the TCGA data. Results We have constructed an in vitro cell model to mimic the EMT in patients. We discovered that several new transcription factors were among the early genes (3 h) to respond to cancer micro-environmental cues which could play critical roles in triggering further EMT signals. The early EMT markers also included genes encoding membrane transporters and blood coagulation function. Three of the nine-examined early EMT hallmark genes, GALNT6, SPARC and HES7, were up-regulated specifically in the early stages of lung adenocarcinoma (LUAD) and confirmed by TCGA patient transcriptome data. In addition, we showed that miR-3613, a regulator of EGFR pathway genes, was constantly repressed during EMT progress and indicative of an epithelial miRNA marker. Conclusions The CAF-stimulated EMT cell model may recapture some of the molecular changes during EMT progression in clinical patients. The identified early EMT hallmark genes GALNT6, SPARC and HES7and miR-3613 provide new markers and therapeutic targets for LUAD for the further clinical diagnosis and drug screening.
Additional File 1 of Identification of a Tumor Microenvironment-Related Seven-Gene Signature for Predicting Prognosis in Bladder Cancer

Zhi Wang,Lei Tu,Minfeng Chen,Seo Yun Tong

DOI: https://doi.org/10.6084/m9.figshare.14767230

2021-01-01

Abstract:Additional file 1: Table S1. GO analysis of 4 TME-related co-expression modules (magenta, brown, purple and yellow).
Supplementary Figure S5 from the N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma

Shiyan Wang,Yong Zeng,Lin Zhu,Min Zhang,Lei Zhou,Weixiong Yang,Weishan Luo,Lina Wang,Yanming Liu,Helen Zhu,Xin Xu,Peiran Su,Xinyue Zhang,Musaddeque Ahmed,Wei Chen,Moliang Chen,Sujun Chen,Mykhaylo Slobodyanyuk,Zhongpeng Xie,Jiansheng Guan,Wen Zhang,Aafaque Ahmad Khan,Shingo Sakashita,Ni Liu,Nhu-An Pham,Paul C. Boutros,Zunfu Ke,Michael F. Moran,Zongwei Cai,Chao Cheng,Jun Yu,Ming S. Tsao,Housheng H. He

DOI: https://doi.org/10.1158/2159-8290.27434168

2024-01-01

Abstract:Live cell imaging of EML4-overexpressing H358 cells in wound healing assay.
Additional File 6 of Comparative Profiling of Single-Cell Transcriptome Reveals Heterogeneity of Tumor Microenvironment Between Solid and Acinar Lung Adenocarcinoma

Dianke Li,Hua Yu,Junjie Hu,Shaoling Li,Yao Yan,Shuangyi Li,Lishan Sun,Gening Jiang,Likun Hou,Lele Zhang,Peng Zhang

DOI: https://doi.org/10.6084/m9.figshare.21192136

2022-01-01

Abstract:Additional file 6: Table S6. Gene list of signatures for fibroblasts.
Additional File 6 of A Human Lung Tumor Microenvironment Interactome Identifies Clinically Relevant Cell-Type Cross-Talk

Andrew J. Gentles,Angela Bik‐Yu Hui,Weiguo Feng,Armon Azizi,Ramesh V. Nair,Gina Bouchard,David A. Knowles,Alice L. Yu,Youngtae Jeong,Alborz Bejnood,Erna Forgó,Sushama Varma,Yue Xu,Amanda Kuong,Viswam S. Nair,Robert B. West,Matt van de Rijn,Chuong D. Hoang,Maximilian Diehn,Sylvia K. Plevritis

DOI: https://doi.org/10.6084/m9.figshare.12270101

2020-01-01

Abstract:Table S6. Differences between average gene expression across transcriptome in bulk vs. reconstructed profiles. Relevant to Fig. 1e.
Supplementary Figure S1 from Molecular Portraits of Epithelial, Mesenchymal, and Hybrid States in Lung Adenocarcinoma and Their Relevance to Survival

Mark J. Schliekelman,Ayumu Taguchi,Jun Zhu,Xudong Dai,Jaime Rodriguez,Muge Celiktas,Qing Zhang,Alice Chin,Chee-Hong Wong,Hong Wang,Lisa McFerrin,Suhaida A. Selamat,Chenchen Yang,Evan M. Kroh,Kavita S. Garg,Carmen Behrens,Adi F. Gazdar,Ite A. Laird-Offringa,Muneesh Tewari,Ignacio I. Wistuba,Jean P. Thiery,Samir M. Hanash

DOI: https://doi.org/10.1158/0008-5472.22406754

2023-01-01

Abstract:Supplementary Figure S1. Background information for lung adenocarcinoma cell lines.
Supplementary Video S2 from the N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma

Shiyan Wang,Yong Zeng,Lin Zhu,Min Zhang,Lei Zhou,Weixiong Yang,Weishan Luo,Lina Wang,Yanming Liu,Helen Zhu,Xin Xu,Peiran Su,Xinyue Zhang,Musaddeque Ahmed,Wei Chen,Moliang Chen,Sujun Chen,Mykhaylo Slobodyanyuk,Zhongpeng Xie,Jiansheng Guan,Wen Zhang,Aafaque Ahmad Khan,Shingo Sakashita,Ni Liu,Nhu-An Pham,Paul C. Boutros,Zunfu Ke,Michael F. Moran,Zongwei Cai,Chao Cheng,Jun Yu,Ming S. Tsao,Housheng H. He

DOI: https://doi.org/10.1158/2159-8290.27434102

2024-01-01

Abstract:Live cell imaging of EML4-overexpressing A549 cells in wound healing assay.
Supplementary Figure S7 from the N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma

Shiyan Wang,Yong Zeng,Lin Zhu,Min Zhang,Lei Zhou,Weixiong Yang,Weishan Luo,Lina Wang,Yanming Liu,Helen Zhu,Xin Xu,Peiran Su,Xinyue Zhang,Musaddeque Ahmed,Wei Chen,Moliang Chen,Sujun Chen,Mykhaylo Slobodyanyuk,Zhongpeng Xie,Jiansheng Guan,Wen Zhang,Aafaque Ahmad Khan,Shingo Sakashita,Ni Liu,Nhu-An Pham,Paul C. Boutros,Zunfu Ke,Michael F. Moran,Zongwei Cai,Chao Cheng,Jun Yu,Ming S. Tsao,Housheng H. He

DOI: https://doi.org/10.1158/2159-8290.27434162

2024-01-01

Abstract:RNA-seq analysis of EML4-overexpressing, EML4-knockdown and control NSCLC cell samples.
Additional File 1: of CXCL9/10/11, a Regulator of PD-L1 Expression in Gastric Cancer

Chenlu Zhang,Zhi Li,Li Xu,Xiaofang Che,Ti Wen,Yibo Fan,Ce Li,S Wang,Chunhao Yu,Xiaoxun Wang,Xiujuan Qu,Yunpeng Liu

DOI: https://doi.org/10.6084/m9.figshare.6181511

2018-01-01

Abstract:Table S1. The first 20 significantly enriched gene pathways in TCGA dataset. (XLS 18Â kb)
Additional File 3: Table S5. of Differential Expression Analysis at the Individual Level Reveals a Lncrna Prognostic Signature for Lung Adenocarcinoma

Fuduan Peng,Ruiping Wang,Yuanyuan Zhang,Zhangxiang Zhao,Wenbin Zhou,Zhiqiang Chang,Haihai Liang,Wenyuan Zhao,Lishuang Qi,Zheng Guo,Yunyan Gu

DOI: https://doi.org/10.6084/m9.figshare.c.3796993_d3

2017-01-01

Abstract:Detail information of differentially expressed lncRNAs identified based on microarray data. (XLSX 275 kb)
Supplementary Video S4 from the N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma

Shiyan Wang,Yong Zeng,Lin Zhu,Min Zhang,Lei Zhou,Weixiong Yang,Weishan Luo,Lina Wang,Yanming Liu,Helen Zhu,Xin Xu,Peiran Su,Xinyue Zhang,Musaddeque Ahmed,Wei Chen,Moliang Chen,Sujun Chen,Mykhaylo Slobodyanyuk,Zhongpeng Xie,Jiansheng Guan,Wen Zhang,Aafaque Ahmad Khan,Shingo Sakashita,Ni Liu,Nhu-An Pham,Paul C. Boutros,Zunfu Ke,Michael F. Moran,Zongwei Cai,Chao Cheng,Jun Yu,Ming S. Tsao,Housheng H. He

DOI: https://doi.org/10.1158/2159-8290.27434093

2024-01-01

Abstract:Live cell imaging of EML4-overexpressing H358 cells in wound healing assay.
Additional File 3 of Exploration of Predictive and Prognostic Alternative Splicing Signatures in Lung Adenocarcinoma Using Machine Learning Methods

Qidong Cai,Boxue He,Pengfei Zhang,Zhenyu Zhao,Ping Xiong,Yuqian Zhang,Haiyang Xie,Xiang Wang

DOI: https://doi.org/10.6084/m9.figshare.13346463

2020-01-01

Abstract:Additional file 3: Table S3. Samples for recognizing lymph node metastasis (LNM).
Additional File 11 of A Novel Signature Derived from Metabolism-Related Genes GPT and SMS to Predict Prognosis of Laryngeal Squamous Cell Carcinoma

Yujie Shen,Qiang Huang,Yifan Zhang,Chi‐Yao Hsueh,Liang Zhou

DOI: https://doi.org/10.6084/m9.figshare.20279354

2022-01-01

Abstract:Additional file 11: Table S5. Enrichment analysis of sub-networks.
Supplementary Table S4 from Molecular Portraits of Epithelial, Mesenchymal, and Hybrid States in Lung Adenocarcinoma and Their Relevance to Survival

Mark J. Schliekelman,Ayumu Taguchi,Jun Zhu,Xudong Dai,Jaime Rodrı́guez,Müge Çeliktaş,Qing Zhang,Alice Chin,Chee-Hong Wong,Hong Wang,Lisa McFerrin,Suhaida A. Selamat,Yang Chao,Evan M. Kroh,Kavita S. Garg,Carmen Behrens,Adi F. Gazdar,Ite A. Laird-Offringa,Muneesh Tewari,Ignacio I. Wistuba,Jean Paul Thiery,Samir Hanash

DOI: https://doi.org/10.1158/0008-5472.22406736

2023-01-01

Abstract:Supplementary Table S4. Aggressive hybrid protein signature and gene ontology.

Additional File 8: of Epithelial-mesenchymal Transition Markers Screened in a Cell-Based Model and Validated in Lung Adenocarcinoma

Additional File 1 of Integration of Single-Cell Regulon Atlas and Multi-Omics Data for Prognostic Stratification and Personalized Treatment Prediction in Human Lung Adenocarcinoma

Supplementary Methods and References from MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer

Supplementary Table 2 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Supplementary Table 2 from MEK Inhibition Modulates Cytokine Response to Mediate Therapeutic Efficacy in Lung Cancer

Supplementary Table 7 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Additional File 8 of the Immune Subtypes and Landscape of Sarcomas

Epithelial-mesenchymal Transition Markers Screened in a Cell-Based Model and Validated in Lung Adenocarcinoma

Additional File 1 of Identification of a Tumor Microenvironment-Related Seven-Gene Signature for Predicting Prognosis in Bladder Cancer

Supplementary Figure S5 from the N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma

Additional File 6 of Comparative Profiling of Single-Cell Transcriptome Reveals Heterogeneity of Tumor Microenvironment Between Solid and Acinar Lung Adenocarcinoma

Additional File 6 of A Human Lung Tumor Microenvironment Interactome Identifies Clinically Relevant Cell-Type Cross-Talk

Supplementary Figure S1 from Molecular Portraits of Epithelial, Mesenchymal, and Hybrid States in Lung Adenocarcinoma and Their Relevance to Survival

Supplementary Video S2 from the N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma

Supplementary Figure S7 from the N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma

Additional File 1: of CXCL9/10/11, a Regulator of PD-L1 Expression in Gastric Cancer

Additional File 3: Table S5. of Differential Expression Analysis at the Individual Level Reveals a Lncrna Prognostic Signature for Lung Adenocarcinoma

Supplementary Video S4 from the N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma

Additional File 3 of Exploration of Predictive and Prognostic Alternative Splicing Signatures in Lung Adenocarcinoma Using Machine Learning Methods

Additional File 11 of A Novel Signature Derived from Metabolism-Related Genes GPT and SMS to Predict Prognosis of Laryngeal Squamous Cell Carcinoma

Supplementary Table S4 from Molecular Portraits of Epithelial, Mesenchymal, and Hybrid States in Lung Adenocarcinoma and Their Relevance to Survival